drugset / Trial / NCT00751101

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

NCT00751101

RandomizedParallel-groupOpen-labelSupportive care

Summary

RATIONALE: Nicotine patches may reduce hand-foot syndrome in patients receiving capecitabine for metastatic breast cancer. It is not yet known which nicotine patch regimen may be more effective in reducing hand-foot syndrome. PURPOSE: This randomized clinical trial is studying which schedule of using nicotine patches is more effective in reducing hand-foot syndrome in patients who are receiving capecitabine for metastatic breast cancer.

Timeline

Start
2007-08-20
Primary completion
2014-03-24
Completion
2018-03-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown Other